WallStreetZenWallStreetZen

NASDAQ: NGNE
Neurogene Inc Stock Ownership - Who owns Neurogene?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Neurogene Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christine Mikail CvijicPresident and CFO2026-07-074,200$36.13
$151.76kSell
Christine Mikail CvijicPresident and CFO2026-07-06600$36.02
$21.61kSell
Christine Mikail CvijicPresident and CFO2026-07-021,530$35.23
$53.90kSell
Christine Mikail CvijicPresident and CFO2026-07-022,531$34.58
$87.52kSell
Christine Mikail CvijicPresident and CFO2026-07-01739$34.06
$25.17kSell
Christine Mikail CvijicPresident and CFO2026-05-064,800$32.44
$155.69kSell
Christine Mikail CvijicPresident and CFO2026-05-064,800$30.07
$144.35kSell
Rachel McMinnChief Executive Officer2026-03-263,352$22.08
$74.00kSell
Christine Mikail CvijicPresident and CFO2026-03-262,558$21.63
$55.32kSell
Julie JordanChief Medical Officer2026-03-26828$21.89
$18.13kSell

1 of 2

NGNE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NGNE insiders and whales buy or sell their stock.

NGNE Shareholders

What type of owners hold Neurogene Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Redmile Group LLC19.32%3,866,579$148.52MInsider
Jonathan G. Drachman11.49%2,298,686$88.29MInsider
Gary Bridger9.61%1,922,775$73.85MInsider
Samsara Biocapital GP LLC8.34%1,668,357$64.08MInsider
Ventures West 8 Limited Partnership7.72%1,543,989$59.30MInsider
Johnson Johnson7.21%1,442,094$55.39MInsider
Carl Walkey6.76%1,352,489$51.95MInsider
Rachel McMinn6.72%1,344,307$51.63MInsider
Baker Bros Advisors LP5.98%1,196,081$45.94MInsider
Pfizer Inc4.87%975,403$37.47MInsider

1 of 3

NGNE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NGNE0.09%89.43%Net SellingNet Selling
MNPR0.03%99.97%Net SellingNet Selling
STTK0.08%15.04%Net BuyingNet Buying
CTMX0.10%10.10%Net SellingNet Selling
GYRE0.01%99.99%Net SellingNet Buying
View Top Biotech Stocks

Neurogene Stock Ownership FAQ

Who owns Neurogene?

Neurogene (NASDAQ: NGNE) is owned by 0.09% institutional shareholders, 89.43% Neurogene insiders, and 10.49% retail investors. Redmile Group LLC is the largest individual Neurogene shareholder, owning 3.87M shares representing 19.32% of the company. Redmile Group LLC's Neurogene shares are currently valued at $146.39M.

If you're new to stock investing, here's how to buy Neurogene stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.